PLUS1
71.15
-32.20 (-31.16%)
-32.20 (-31.16%)
Upgrade to Real-Time
Afterhours (Closed)
Low
2.78
High
146.16
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Cassava Sciences Inc | SAVA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -32.20 | -31.16% | 71.15 | 19:59:20 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 88.00 | 65.00 | 95.15 | 69.53 | 103.35 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 71.01 | 71.19 | 0.18 | - | 1 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 263,884 | 25,195,106 | $ 79.40 | $ 2,000,466,347 | - | 2.78 - 146.16 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:59:17 | formt | 200 | $ 71.15 | USD |
Period:
Draw Mode:
Cassava Sciences Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 2.85B | 40.01M | 37.92M | $ - | $ - | -0.25 | -466.60 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | -53.97k | 5.80% |
Cassava Sciences News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SAVA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 124.50 | 146.16 | 65.00 | 114.34 | 7,523,510 | -53.35 | -42.85% |
| 1 Month | 89.40 | 146.16 | 65.00 | 107.20 | 4,771,552 | -18.25 | -20.41% |
| 3 Months | 41.68 | 146.16 | 36.0503 | 88.15 | 3,106,550 | 29.47 | 70.71% |
| 6 Months | 20.50 | 146.16 | 19.01 | 66.83 | 4,663,763 | 50.65 | 247.07% |
| 1 Year | 3.30 | 146.16 | 2.78 | 36.15 | 4,985,027 | 67.85 | 2,056.06% |
| 3 Years | 1.21 | 146.16 | 1.00 | 25.28 | 3,245,776 | 69.94 | 5,780.17% |
| 5 Years | 1.21 | 146.16 | 1.00 | 25.28 | 3,245,776 | 69.94 | 5,780.17% |
Cassava Sciences Description
| Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. |
